DICER inactivation identifies pancreatic β-cell “disallowed” genes targeted by microRNAs

Molecular Endocrinology

Volumn 29, Issue 7, 2015, Pages 1067-1079

  Martinez Sanchez, Aida ^a   Nguyen Tu, Marie Sophie ^a   Rutter, Guy A ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DICER; FC RECEPTOR; INSULIN; LUCIFERASE; MICRORNA; MONOCARBOXYLATE TRANSPORTER 1; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; RIBONUCLEASE III; SOMATOMEDIN BINDING PROTEIN 4; TRANSCRIPTION FACTOR MAF; TRANSCRIPTION FACTOR PDX 1; CRE RECOMBINASE; GLUCOSE; HOMEODOMAIN PROTEIN; INTEGRASE; PANCREATIC AND DUODENAL HOMEOBOX 1 PROTEIN; TAMOXIFEN; TRANSACTIVATOR PROTEIN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; HYPERGLYCEMIA; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; PROTEIN DOMAIN; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENE; UPREGULATION; ANIMAL; APOPTOSIS; C57BL MOUSE; COMPLICATION; DEFICIENCY; DRUG EFFECTS; GENE DELETION; GENETICS; GLUCOSE INTOLERANCE; METABOLISM;

MAMMALIA;

ANIMALS; APOPTOSIS; GENE DELETION; GLUCOSE; GLUCOSE INTOLERANCE; HOMEODOMAIN PROTEINS; HYPERGLYCEMIA; INSULIN; INSULIN-SECRETING CELLS; INTEGRASES; MICE, INBRED C57BL; MICRORNAS; RIBONUCLEASE III; TAMOXIFEN; TRANS-ACTIVATORS; UP-REGULATION;

EID: 84936123498     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2015-1059     Document Type: Article

References (63)

1. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103:137–149.
2. Rutter GA, Pullen TJ, Hodson DJ, Martinez-Sanchez A. Pancreatic β cell identity, glucose sensing and the control of insulin secretion. Biochem J. 2015;466:202–218.
3. Henquin JC. Regulation of insulin secretion: a matter of phase control and amplitude modulation. Diabetologia. 2009;52:739–751.
4. Prentki M, Matschinsky FM, Madiraju SR. Metabolic signaling in fuel-induced insulin secretion. Cell Metab. 2013;18:162–185.
5. Pullen TJ, Rutter GA. When less is more: the forbidden fruits of gene repression in the adult β-cell. Diabetes Obes Metab. 2013;15: 503–512.
6. Pullen TJ, Khan AM, Barton G, Butcher SA, Sun G, Rutter GA. Identification of genes selectively disallowed in the pancreatic islet. Islets. 2010;2:89–95.
7. Thorrez L, Laudadio I, Van Deun K, et al. Tissue-specific disallowance of housekeeping genes: the other face of cell differentiation. Genome Res. 2011;21:95–105.
8. Quintens R, Hendrickx N, Lemaire K, Schuit F. Why expression of some genes is disallowed in beta-cells. Biochem Soc Trans. 2008; 36:300–305.
9. Sekine N, Cirulli V, Regazzi R, et al. Low lactate dehydrogenase and high mitochondrial glycerol phosphate dehydrogenase in pancreatic β-cell. Potential role in nutrient sensing. J Biol Chem. 1994; 269:4895–4902.
10. Otonkoski T, Jiao H, Kaminen-Ahola N, et al. Physical exerciseinduced hypoglycemia caused by failed silencing of monocarboxylate transporter 1 in pancreatic β cells. Am J Hum Genet. 2007;81: 467–474.
11. Pullen TJ, Sylow L, Sun G, Halestrap AP, Richter EA, Rutter GA. Overexpression of monocarboxylate transporter-1 (Slc16a1) in mouse pancreatic β-cells leads to relative hyperinsulinism during exercise. Diabetes. 2012;61:1719–1725.
12. Poy MN, Hausser J, Trajkovski M, et al. miR-375 maintains normal pancreatic β- and β-cell mass. Proc Natl Acad Sci USA. 2009; 106:5813–5818.
13. Setyowati Karolina D, Sepramaniam S, Tan HZ, Armugam A, Jeyaseelan K. miR-25 and miR-92a regulate insulin I biosynthesis in rats. RNA Biol. 2013;10:1365–1378.
14. Xu G, Chen J, Jing G, Shalev A. Thioredoxin-interacting protein regulates insulin transcription through microRNA-204. Nat Med. 2013;19:1141–1146.
15. Zhang ZW, Zhang LQ, Ding L, et al. MicroRNA-19b downregulates insulin 1 through targeting transcription factor NeuroD 1. FEBS Lett. 2011;585:2592–2598.
16. Melkman-Zehavi T, Oren R, Kredo-Russo S, et al. miRNAs control insulin content in pancreatic β-cells via downregulation of transcriptional repressors. EMBO J. 2011;30:835–845.
17. Nieto M, Hevia P, Garcia E, et al. Antisense miR-7 impairs insulin expression in developing pancreas and in cultured pancreatic buds. Cell Transplant. 2012;21:1761–1774.
18. Lovis P, Gattesco S, Regazzi R. Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs. Biol Chem. 2008;389:305–312.
19. Latreille M, Hausser J, Stützer I, et al. MicroRNA-7a regulates pancreatic β cell function. J Clin Invest. 2014;124:2722–2735.
20. Tattikota SG, Rathjen T, McAnulty SJ, et al. Argonaute2 mediates compensatory expansion of the pancreatic β cell. Cell Metab. 2014; 19:122–134.
21. Ruan Q, Wang T, Kameswaran V, et al. The microRNA-21- PDCD4 axis prevents type 1 diabetes by blocking pancreatic β cell death. Proc Natl Acad Sci USA. 2011;108:12030–12035.
22. Lovis P, Roggli E, Laybutt DR, et al. Alterations in microRNA expression contribute to fatty acid-induced pancreatic β-cell dysfunction. Diabetes. 2008;57:2728–2736.
23. Lynn FC, Skewes-Cox P, Kosaka Y, McManus MT, Harfe BD, German MS. MicroRNA expression is required for pancreatic islet cell genesis in the mouse. Diabetes. 2007;56:2938–2945.
24. Kalis M, Bolmeson C, Esguerra JL, et al. β-Cell specific deletion of Dicer1 leads to defective insulin secretion and diabetes mellitus. PLoS One. 2011;6:e29166.
25. Mandelbaum AD, Melkman-Zehavi T, Oren R, et al. Dysregulation of dicer1 in β cells impairs islet architecture and glucose metabolism. Exp Diabetes Res. 2012;2012:470302.
26. Guay C, Jacovetti C, Nesca V, et al. Emerging roles of non-coding RNAs in pancreatic β-cell function and dysfunction. Diabetes Obes Metab. 2012;14(Suppl 3):12–21.
27. van Arensbergen J, García-Hurtado J, Maestro MA, et al. Ring1b bookmarks genes in pancreatic embryonic progenitors for repression in adult β cells. Genes Dev. 2013;27:52–63.
28. Gu G, Dubauskaite J, Melton DA. Direct evidence for the pancreatic lineage: NGN3β cells are islet progenitors and are distinct from duct progenitors. Development. 2002;129:2447–2457.
29. Soyer J, Flasse L, Raffelsberger W, et al. Rfx6 is an Ngn3-dependent winged helix transcription factor required for pancreatic islet cell development. Development. 2010;137:203–212.
30. Piccand J, Strasser P, Hodson DJ, et al. Rfx6 maintains the functional identity of adult pancreatic β-cells. Cell Rep. 2014;9:2219–2232.
31. Pullen TJ, da Silva Xavier G, Kelsey G, Rutter GA. miR-29a and miR-29b contribute to pancreatic β-cell-specific silencing of monocarboxylate transporter 1 (Mct1). Mol Cell Biol. 2011;31:3182–3194.
32. Gannon M, Herrera PL, Wright CV. Mosaic Cre-mediated recombination in pancreas using the pdx-1 enhancer/promoter. Genesis. 2000;26:143–144.
33. Gannon M, Shiota C, Postic C, Wright CV, Magnuson M. Analysis of the Cre-mediated recombination driven by rat insulin promoter in embryonic and adult mouse pancreas. Genesis. 2000;26:139–142.
34. Kanji MS, Martin MG, Bhushan A. Dicer1 is required to repress neuronal fate during endocrine cell maturation. Diabetes. 2013;62: 1602–1611.
35. Wicksteed B, Brissova M, Yan W, et al. Conditional gene targeting in mouse pancreatic β-cells: analysis of ectopic Cre transgene expression in the brain. Diabetes. 2010;59:3090–3098.
36. Cobb BS, Nesterova TB, Thompson E, et al. T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer. J Exp Med. 2005;201:1367–1373.
37. Ravier MA, Rutter GA. Isolation and culture of mouse pancreatic islets for ex vivo imaging studies with trappable or recombinant fluorescent probes. Methods Mol Biol. 2010;633:171–184.
38. Sun G, Tarasov AI, McGinty JA, et al. LKB1 deletion with the RIP2.Cre transgene modifies pancreatic β-cell morphology and enhances insulin secretion in vivo. Am J Physiol Endocrinol Metab. 2010;298:E1261–E1273.
39. Ha M, Kim VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol. 2014;15:509–524.
40. Kone M, Pullen TJ, Sun G, et al. LKB1 and AMPK differentially regulate pancreatic β-cell identity. FASEB J. 2014;28:4972–4985.
41. Klein D, Misawa R, Bravo-Egana V, et al. MicroRNA expression in β andβ cells of human pancreatic islets. PLoS One. 2013;8:e55064.
42. Meier JJ, Bonadonna RC. Role of reduced β-cell mass versus impaired β-cell function in the pathogenesis of type 2 diabetes. Diabetes Care. 2013;36(Suppl 2):S113–S119.
43. Talchai C, Xuan S, Lin HV, Sussel L, Accili D. Pancreatic β celldedifferentiation as a mechanism of diabetic β cell failure. Cell. 2012;150:1223–1234.
44. Morita S, Hara A, Kojima I, et al. Dicer is required for maintaining adult pancreas. PLoS One. 2009;4:e4212.
45. Rosero S, Bravo-Egana V, Jiang Z, et al. MicroRNA signature of the human developing pancreas. BMC Genomics. 2010;11:509.
46. Francis N, Moore M, Rutter GA, Burns C. The role of microRNAs in the pancreatic differentiation of pluripotent stem cells. Microrna. 2014;3:54–63.
47. Poy MN, Eliasson L, Krutzfeldt J, et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature. 2004;432:226–230.
48. Plaisance V, Abderrahmani A, Perret-Menoud V, Jacquemin P, Lemaigre F, Regazzi R. MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells. J Biol Chem. 2006;281:26932–26942.
49. Nesca V, Guay C, Jacovetti C, et al. Identification of particular groups of microRNAs that positively or negatively impact on beta cell function in obese models of type 2 diabetes. Diabetologia. 2013;56:2203–2212.
50. Kataoka K, Shioda S, Ando K, Sakagami K, Handa H, Yasuda K. Differentially expressed Maf family transcription factors, c-Maf and MafA, activate glucagon and insulin gene expression in pancreatic islet β- and β-cells. J Mol Endocrinol. 2004;32:9–20.
51. Gosmain Y, Cheyssac C, Heddad Masson M, Dibner C, Philippe J. Glucagon gene expression in the endocrine pancreas: the role of the transcription factor Pax6 in β-cell differentiation, glucagon biosynthesis and secretion. Diabetes Obes Metab. 2011;13(Suppl 1):31–38.
52. Beitzinger M, Peters L, Zhu JY, Kremmer E, Meister G. Identification of human microRNA targets from isolated argonaute protein complexes. RNA Biol. 2007;4:76–84.
53. Baroukh N, Ravier MA, Loder MK, et al. MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic β-cell lines. J Biol Chem. 2007;282:19575–19588.
54. Kim JW, You YH, Jung S, et al. miRNA-30a–5p-mediated silencing of Beta2/NeuroD expression is an important initial event of glucotoxicity- induced β cell dysfunction in rodent models. Diabetologia. 2013;56:847–855.
55. Pullen TJ, Sylow L, Sun G, Halestrap AP, Richter EA, Rutter GA. Overexpression of monocarboxylate transporter-1 (Slc16a1) in mouse pancreatic β-cells leads to relative hyperinsulinism during exercise. Diabetes. 2012;61:1719–1725.
56. Zhao C, Rutter GA. Overexpression of lactate dehydrogenase A attenuates glucose-induced insulin secretion in stable MIN-6 β-cell lines. FEBS Lett. 1998;430:213–216.
57. Gosmain Y, Avril I, Mamin A, Philippe J. Pax-6 and c-Maf functionally interact with the β-cell-specific DNA element G1 in vivo to promote glucagon gene expression. J Biol Chem. 2007;282:35024–35034.
58. Zhai PF, Wang F, Su R, et al. The regulatory roles of microRNA- 146b–5p and its target platelet-derived growth factor receptor β (PDGFRA) in erythropoiesis and megakaryocytopoiesis. J Biol Chem. 2014;289:22600–22613.
59. Garofalo M, Jeon YJ, Nuovo GJ, et al. MiR-34a/c-dependent PDGFR-β/β downregulation inhibits tumorigenesis and enhances TRAIL-induced apoptosis in lung cancer. PLoS One. 2013;8: e67581.
60. Vetere A, Choudhary A, Burns SM, Wagner BK. Targeting the pancreatic β-cell to treat diabetes. Nat Rev Drug Discov. 2014;13: 278–289.
61. Maechler P, Wollheim CB. Mitochondrial glutamate acts as a messenger in glucose-induced insulin exocytosis. Nature. 1999;402: 685–689.
62. Gheni G, Ogura M, Iwasaki M, et al. Glutamate acts as a key signal linking glucose metabolism to incretin/cAMP action to amplify insulin secretion. Cell Rep. 2014;9:661–673.
63. Rath T, Baker K, Pyzik M, Blumberg RS. Regulation of immune responses by the neonatal fc receptor and its therapeutic implications. Front Immunol. 2014;5:664.